| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |